Treatment of non-small-cell lung cancer with erlotinib or gefitinib
- PMID: 21388312
- DOI: 10.1056/NEJMct0807960
Treatment of non-small-cell lung cancer with erlotinib or gefitinib
Abstract
A 64-year-old woman receives the diagnosis of metastatic non-small-cell lung cancer (NSCLC), which has progressed during treatment with carboplatin, paclitaxel, and bevacizumab. Erlotinib therapy is recommended.
Comment in
-
Erlotinib or gefitinib for non-small-cell lung cancer.N Engl J Med. 2011 Jun 16;364(24):2367; author reply 2368. doi: 10.1056/NEJMc1103918. N Engl J Med. 2011. PMID: 21675909 No abstract available.
-
Erlotinib or gefitinib for non-small-cell lung cancer.N Engl J Med. 2011 Jun 16;364(24):2367; author reply 2368. doi: 10.1056/NEJMc1103918. N Engl J Med. 2011. PMID: 21675910 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical